Meningioma Trials
- SOM230-C TRIAL for Meningiomas - A Phase II study of SOM230C in patients with recurrent or progressive meningioma who have previously undergone or are not candidates for additional surgery or radiation (more information)
To schedule an appointment 1-800-CEDARS-1 (1-800-233-2771) OR EMAIL US HERE